Stem cells for chronic rejection in kidney transplant
Part of Immune system & allergy, Kidney & urinary clinical trials.
This trial tests whether using special cells called mesenchymal stem cells (MSCs) can help treat chronic active antibody-mediated rejection—a long-term rejection inside a kidney transplant. It is for kidney transplant patients who are experiencing this specific type of rejection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had a kidney transplant.
- You must have chronic active antibody-mediated rejection (a long-term rejection condition) in that transplanted kidney.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication called belatacept to see if it can prevent or treat early antibody-mediated rejection in kidney transplant recipients who have developed new donor-specific antibodies but still have stable kidney function.
This trial tests a new treatment using your own immune cells, called tolerogenic dendritic cells, to help your body accept a kidney transplant. It is designed for people who are highly sensitized and have a very hard time finding a matching donor kidney.
This trial tests whether a single injection of umbilical cord cells can stop or slow chronic antibody-mediated rejection in kidney transplant patients who haven't improved with standard IV-IG therapy. It aims to reduce damage to the transplanted kidney.
This study tests whether a single infusion of stem cells from bone marrow is safe for people with chronic kidney disease (CKD). It aims to see if this treatment can help slow kidney function loss.
This trial tests whether a type of stem cell therapy can help people with chronic kidney disease caused by diabetes or high blood pressure. It aims to see if the treatment is safe and can slow kidney damage.
This trial tests a new approach to treat T-cell mediated rejection in kidney transplant recipients. It aims to safely and effectively stop the rejection episode.
Hear when a new Kidney Transplant Rejection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.